Delve into our extensive collection of clinically published studies showcasing real-world evidence.
Viz™ ANEURYSM
In a retrospective evaluation of incidental aneurysms 2mm or larger in 1191 consecutive CTAs for stroke evaluation, 26% of AI-identified...
Feb 02, 2023
Viz™ ICH
Viz.ai more accurately estimates ICH volume than ABC/2 over a broad range of hematoma volumes when compared to standard semi-automated...
Feb 02, 2023
Viz™ LVO
In this multicenter cohort study, implementation of automated LVO detection with coupled care-team communication tool improved PSC transfer performance by...
Feb 02, 2023
Viz™ LVO
Consistent with our initial 6 month post-implementation pilot, we noted sustainability over a 17 month period with sustained reduction in...
Feb 02, 2023
Viz Recruit
Prior to implementation of the AI-based software, there were 5 patients enrolled (0.99 patients/month). After implementation of the software for...
Feb 02, 2023
Viz™ CTP
Comparison of scores for identifying patients with vertebrobasilar occlusions who may benefit from EVT.
Feb 02, 2023
Viz™ LVO
In a multi-center cluster randomized trial, implementation of an automated LVO detection software with care team-wide communication did not significantly...
Feb 02, 2023
Viz™ LVO
In a multi-center cluster randomized trial, implementation of an automated LVO detection algorithm improved treatment times [median DTG] in patients...
Feb 02, 2023
Viz™ LVO
There was a prominent reduction in CTA performed in the United States due to contrast media shortage. However, the proportion...
Feb 02, 2023
